A drug that has passed phase 1 trials for spinal injuries in people repaired DNA breaks and reduced inflammation in mouse ...
Eleven new molecular drug targets receive approval in 2025, expanding treatment options for rare diseases, cancer, and infectious diseases.
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results